Support

์ด์šฉ์•ฝ๊ด€ ๋ฐ ๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ ๋ณ€๊ฒฝ ์•ˆ๋‚ด

2024-04-2329

๋ฉ”๋””ํด๋ ˆ์˜ค ์ด์šฉ์•ฝ๊ด€ ๋ฐ ๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ ๋ณ€๊ฒฝ ์•ˆ๋‚ด

 

์•ˆ๋…•ํ•˜์„ธ์š”. ๋ฉ”๋””ํด๋ ˆ์˜ค ์ž…๋‹ˆ๋‹ค.

ํ•ญ์ƒ ๋ฉ”๋””ํด๋ ˆ์˜ค๋ฅผ ์ด์šฉํ•ด ์ฃผ์‹œ๋Š” ํšŒ์›๋‹˜๊ป˜ ์ง„์‹ฌ์œผ๋กœ ๊ฐ์‚ฌ ๋“œ๋ฆฝ๋‹ˆ๋‹ค.

ใ€Œ์ด์šฉ์•ฝ๊ด€ใ€ ๋ฐ ใ€Œ๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจใ€์ด ๋‹ค์Œ๊ณผ ๊ฐ™์ด ๋ณ€๊ฒฝ๋  ์˜ˆ์ •์ด์˜ค๋‹ˆ ์ด์šฉ์— ์ฐธ๊ณ ํ•ด ์ฃผ์‹œ๊ธฐ ๋ฐ”๋ž๋‹ˆ๋‹ค.

  1. ๋ณ€๊ฒฝ ๋Œ€์ƒ: ์ด์šฉ์•ฝ๊ด€, ๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ

  2. ์‹œํ–‰์ผ: 2024๋…„ 05์›” 17์ผ

  3. ๊ธฐ์กด ํšŒ์›์— ๋Œ€ํ•œ ์ ์šฉ ์—ฌ๋ถ€: ์ ์šฉ

  4. ์ฃผ์š” ๋ณ€๊ฒฝ: ์ด์šฉ์•ฝ๊ด€

    1. (๋ณ€๊ฒฝ ์ „) ์ด์šฉ์•ฝ๊ด€(2021๋…„ 11์›” 05์ผ ์‹œํ–‰)

    2. (๋ณ€๊ฒฝ ํ›„) ์ด์šฉ์•ฝ๊ด€(2024๋…„ 05์›” 17์ผ ์‹œํ–‰)

  5. ์ฃผ์š” ๋ณ€๊ฒฝ: ๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ

    1. (๋ณ€๊ฒฝ ์ „) ๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ(2023๋…„ 09์›” 15์ผ ์‹œํ–‰)

    2. (๋ณ€๊ฒฝ ํ›„) ๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ(2024๋…„ 05์›” 17์ผ ์‹œํ–‰)

์ด์šฉ์•ฝ๊ด€ ๋ฐ ๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ ๋ณ€๊ฒฝ์— ๋™์˜ํ•˜์ง€ ์•Š๋Š” ๊ฒฝ์šฐ์—๋Š” ๋ณ€๊ฒฝ ์‹œํ–‰์ผ ์ „์˜ ์˜์—…์ผ๊นŒ์ง€ ์ด์šฉ๊ณ„์•ฝ์„ ํ•ด์ง€ํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ๊ณ„์•ฝํ•ด์ง€์˜ ์˜์‚ฌ ํ‘œ์‹œ๋ฅผ ํ•˜์ง€ ์•Š์€ ๊ฒฝ์šฐ์—๋Š” ๋ณ€๊ฒฝ์— ๋™์˜ํ•œ ๊ฒƒ์œผ๋กœ ๋ด…๋‹ˆ๋‹ค.

๋ฉ”๋””ํด๋ ˆ์˜ค ๋“œ๋ฆผ

MediCLEO (CLEO) safely and transparently connects participants with clinical and bioequivalence trials. See ongoing trials at a glance and apply with ease.

์ŠคํŽ˜๋กœ ์ฃผ์‹ํšŒ์‚ฌ ยท CEO ์กฐ๋ฏธํ˜„ ยท ์„œ์šธํŠน๋ณ„์‹œ ๋งˆํฌ๊ตฌ ์–‘ํ™”๋กœ 19, 4์ธต(ํ•ฉ์ •๋™, ํ•ฉ์ •์˜คํ”ผ์Šค๋นŒ๋”ฉ)

Business Registration No. 367-86-01018 ยท Tel 010-2604-0216

ยฉ 2026 ๋ฉ”๋””ํด๋ ˆ์˜ค. Participation in a clinical trial should be decided voluntarily after a full explanation.